Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2015

View Archived Issues

Modified cobratoxin RPI-78M granted U.S. orphan status for pediatric multiple sclerosis

Ex scientia delivers first compound in Sumitomo Dainippon collaboration

Incyte and Jiangsu Hengrui Medicine sign global license agreement for SHR-120

Novimmune and Baxalta form collaboration to discover bispecific antibodies

Redx and Horizon Discovery establish cancer research collaboration

Department of Defense awards Cleveland BioLabs contract for development of entolimod

Prostate tissue accumulation inconsistent with absorption-enhanced formulation of DIM

Dose-response effects described for encenicline in schizophrenia

Patupilone active against brain metastases from non-small cell lung cancer

Cellsight Technologies PET tracer [18F]F-AraG first-in-human results are positive

FORUM Pharmaceuticals describes PDE9A inhibitors that may improve cognition

Daiichi Sankyo discloses RuvB-like 1/RuvB-like 2 complex ATPase inhibitors

Bionomics presents new VEGFR-3/FAK inhibitors

Novartis' Farydak receives E.U. approval for multiple myeloma

Achillion discovers complement factor D inhibitors

Boehringer Ingelheim discloses neutrophil elastase inhibitors

Bristol-Myers Squibb introduces HIV integrase inhibitors

FDA extends PDUFA date for Kanuma

Relief Therapeutics licenses atexakin alfa rights from Merck Serono

FDA grants priority review to daratumumab BLA for multiple myeloma

Allergan to acquire ocular device company AqueSys

FDA approves Xuriden for hereditary orotic aciduria

Terumo's autologous skeletal myoblast sheets approved in Japan for heart failure

Audentes Therapeutics acquires Cardiogen Sciences

Glenmark completes phase I studies for GBR-830

Exploratory trial of SAGE-547 in essential tremor shows significant reduction in tremor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...